Aurora Cannabis (ACB) Competitors

Cronos Group (TSE:CRON) and Aurora Cannabis (TSE:ACB) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, risk, media sentiment, profitability, community ranking and earnings.

Do analysts recommend CRON or ACB?

Cronos Group presently has a consensus target price of C$3.18, indicating a potential upside of 11.19%. Aurora Cannabis has a consensus target price of C$5.69, indicating a potential downside of 4.25%. Given Cronos Group's higher probable upside, equities analysts clearly believe Cronos Group is more favorable than Aurora Cannabis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Aurora Cannabis	0 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.25

Which has stronger earnings & valuation, CRON or ACB?

Aurora Cannabis has higher revenue and earnings than Cronos Group. Cronos Group is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	C$101.78M	10.74	-C$57.37M	-C$0.21	-13.62
Aurora Cannabis	C$278.98M	1.16	-C$30.32M	-C$0.63	-9.43

Does the media favor CRON or ACB?

In the previous week, Aurora Cannabis had 7 more articles in the media than Cronos Group. MarketBeat recorded 9 mentions for Aurora Cannabis and 2 mentions for Cronos Group. Aurora Cannabis' average media sentiment score of 1.19 beat Cronos Group's score of 0.44 indicating that Aurora Cannabis is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cronos Group	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Aurora Cannabis	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals and insiders believe in CRON or ACB?

16.0% of Cronos Group shares are owned by institutional investors. Comparatively, 13.4% of Aurora Cannabis shares are owned by institutional investors. 46.4% of Cronos Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Does the MarketBeat Community believe in CRON or ACB?

Aurora Cannabis received 459 more outperform votes than Cronos Group when rated by MarketBeat users. Likewise, 63.08% of users gave Aurora Cannabis an outperform vote while only 50.74% of users gave Cronos Group an outperform vote.

Company	Underperform	Outperform
Cronos Group	Outperform Votes 69 50.74%	Underperform Votes 67 49.26%
Aurora Cannabis	Outperform Votes 528 63.08%	Underperform Votes 309 36.92%

Which has more volatility & risk, CRON or ACB?

Cronos Group has a beta of 1.02, suggesting that its share price is 2% more volatile than the S&P 500. Comparatively, Aurora Cannabis has a beta of 2.71, suggesting that its share price is 171% more volatile than the S&P 500.

Is CRON or ACB more profitable?

Aurora Cannabis has a net margin of -11.53% compared to Cronos Group's net margin of -56.43%. Cronos Group's return on equity of -5.29% beat Aurora Cannabis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	-56.43%	-5.29%	-3.73%
Aurora Cannabis	-11.53%	-6.13%	-1.87%

Summary

Aurora Cannabis beats Cronos Group on 12 of the 18 factors compared between the two stocks.